消化器 / 肝臓 / 集中治療

急性肝不全 — 管理パス

慢性肝疾患なしの脳症+凝固障害。早期NAC、早期に移植施設へ搬送。

根拠:King's College。各ノードはガイドラインの判断ロジックを要約したものであり、原文の転載ではありません。 医療従事者向けの参考情報であり、臨床判断の代替ではありません。日本の関連学会指針および施設プロトコルを優先してください。

ステップごとに回答すると、結論と対応の目安が表示されます。前の質問に戻ることもできます。

ステップ 1 · King's College criteria
Etiology? Do King's College transplant criteria apply?
💡 ALF = hepatic encephalopathy + coagulopathy (INR ≥1.5) within 26 weeks in someone without chronic liver disease. Etiologies: acetaminophen, viral hepatitis (HBV important in some regions), drugs, autoimmune, Wilson's, toxic mushrooms, etc. King's College criteria (predict poor prognosis/need for transplant) — acetaminophen: pH <7.30 (after resuscitation), or all of INR >6.5 + Cr >300 µmol/L + grade III–IV encephalopathy; non-acetaminophen: INR >6.5 alone, or any three of (age <10/>40, non-A non-B hepatitis/drug/Wilson etiology, jaundice-to-encephalopathy >7 days, INR >3.5, bilirubin >300 µmol/L).

パス全体像

  1. 【判断】King's College criteria
    Etiology? Do King's College transplant criteria apply?ALF = hepatic encephalopathy + coagulopathy (INR ≥1.5) within 26 weeks in someone without chronic liver disease. Etiologies: acetaminophen, viral hepatitis (HBV important in some regions), drugs, autoimmune, Wilson's, toxic mushrooms, etc. King's College criteria (predict poor prognosis/need for transplant) — acetaminophen: pH <7.30 (after resuscitation), or all of INR >6.5 + Cr >300 µmol/L + grade III–IV encephalopathy; non-acetaminophen: INR >6.5 alone, or any three of (age <10/>40, non-A non-B hepatitis/drug/Wilson etiology, jaundice-to-encephalopathy >7 days, INR >3.5, bilirubin >300 µmol/L).
    • Meets King's College criteria / severeCriteria met → early transfer to transplant center
    • Criteria not met / earlyEarly · support + NAC
  2. 【終点】Early · support + NAC
    ICU monitoring, aggressive support — give N-acetylcysteine (NAC)の場合acetaminophen cannot be excluded (also beneficial earlyでnon-acetaminophen ALF); monitor neuro/coagulation/glucose/electrolytes/blood gas; manage hypoglycemia, cerebral edema, 感染 (low thresholdに対し抗菌薬); do not give prophylactic FFP (unless active 出血/before a procedure,・it confounds INR monitoring); reassess serially, transferに対し移植 once criteria are met.
  3. 【終点】Criteria met → early transfer to transplant center
    King's College criteria met / 重症 (poor 予後): transfer earlyへa liver 移植 center (time-critical). Continue NAC; intensive ICU support: cerebral 浮腫/raised ICP (grade III–IV — head elevation, hypertonic saline/mannitol, avoid hypercapnia), frequent 血糖 checksへprevent hypoglycemia, AKI/renal replacement, broad-spectrum antimicrobials/antifungals (low threshold), correct 電解質/metabolic derangements, circulatory support; transfuse FFPに対しcoagulopathy only 〜あり active 出血/before a procedure. Etiology-specific treatment (antiviralsに対しHBV, penicillin/silibininに対しtoxic mushrooms, etc.).

よくある質問

急性肝不全 — 管理パスはどの臨床課題を扱う診療パスですか?
慢性肝疾患なしの脳症+凝固障害。早期NAC、早期に移植施設へ搬送。
急性肝不全 — 管理パスの主要な意思決定ステップは何ですか?
King's College criteria
急性肝不全 — 管理パスはどのような対応方針を示しますか?
Early · support + NAC:ICU monitoring, aggressive support — give N-acetylcysteine (NAC)の場合acetaminophen cannot be excluded (also beneficial earlyでnon-acetaminophen ALF); monitor neuro/coagulation/glucose/electrolytes/blood gas; manage hypoglycemia, cerebral edema, 感染 (low thresholdに対し抗菌薬); do not give prophylactic FFP (unless active 出血/before a procedure,・it confounds INR monitoring); reassess serially, transferに対し移植 once criteria are met.;Criteria met → early transfer to transplant center:King's College criteria met / 重症 (poor 予後): transfer earlyへa liver 移植 center (time-critical). Continue NAC; intensive ICU support: cerebral 浮腫/raised ICP (grade III–IV — head elevation, hypertonic saline/m…
急性肝不全 — 管理パスのうち直ちに対応が必要な状況はどれですか?
Criteria met → early transfer to transplant center:King's College criteria met / 重症 (poor 予後): transfer earlyへa liver 移植 center (time-critical). Continue NAC; intensive ICU support: cerebral 浮腫/raised ICP (grade III–IV — head elevation, hypertonic saline/mannitol, avoid hypercapnia), frequent 血糖 checksへprevent hypoglycemia, AKI/renal replacement, broad-spectrum antimicrobials/antifungals (low threshold), correct 電解質/metabolic derangements, circulatory support; transfuse FFPに対しcoagulopathy only 〜あり active 出血/before a procedure. Etiology-specific treatment (antiviralsに対しHBV, penicillin/silibini…
急性肝不全 — 管理パスはどのガイドラインに基づいていますか?
King's College criteria (O'Grady 1989); BSG/AASLD acute liver failure · 準拠:King's College

出典

  • King's College criteria (O'Grady 1989); BSG/AASLD acute liver failure

← 診療パス一覧へ · English · 中文